Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmunre diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: A gas suppression device for a lithium-sulfur battery includes a voltage measurement unit to measure a voltage of the lithium-sulfur battery; a current application unit to apply an electric current; and a control unit configured to control the current application unit to maintain the voltage of the lithium-sulfur battery within a predetermined range based on a voltage measurement result of the voltage measurement unit, to suppress gas generation in the lithium-sulfur battery having gone through an activation step.

Abstract: An unstructured document analysis method according to an embodiment includes: operations of acquiring unstructured document data including font characteristic data and document structure data, extracting text included in the unstructured document data on the basis of the font characteristic data or the document structure data, classifying the extracted text into a pre-classified item using a trained neural network model, acquiring a content query related to the content included in the unstructured document data and associated with the pre-classified item, and generating an answer to the content query on the basis of the extracted text classified into the item.

Abstract: Disclosed herein are a recombinant adenovirus comprising tissue-specific promoters and trans-splicing ribozymes targeting tumor-specific genes, and uses thereof. More specifically, disclosed herein are a recombinant adenovirus comprising (1) a tissue-specific promoter, (2) a trans-splicing ribozyme acting on tumor-specific genes operably linked to the promoter, and (3) a therapeutic or reporter gene linked to 3? exon of the ribozyme, an anticancer pharmaceutical composition comprising the same, and a composition for cancer diagnosis comprising the same. The recombinant adenovirus exhibits high specificity and significantly improved therapeutic efficacy to gene targeted tissues. Accordingly, the recombinant adenovirus is useful as a gene delivery vector for anticancer agents or cancer diagnostics.

Abstract: Methods, compositions and kits are provided for labeling, copying and/or amplifying nucleic acids. The methods, compositions and kit can be used for a variety of applications, for example, genome-wide scanning applications such as CGH or location analysis.

Abstract: The invention relates to methods and kits for quantification of amplified nucleic acids, such as genomic DNA. The methods and kits can be used to assess bias in an amplification procedure such as a whole genome amplification procedure. In one aspect, the method comprises performing an enzyme-based amplification procedure and validating the results of the procedure using a signal amplification method.